PAZZAGLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 12.741
EU - Europa 8.066
AS - Asia 4.450
SA - Sud America 550
AF - Africa 139
OC - Oceania 92
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.042
Nazione #
US - Stati Uniti d'America 12.642
PL - Polonia 2.414
RU - Federazione Russa 2.287
SG - Singapore 1.337
CN - Cina 858
HK - Hong Kong 789
IT - Italia 738
IE - Irlanda 581
SE - Svezia 553
VN - Vietnam 470
BR - Brasile 449
KR - Corea 391
DE - Germania 321
UA - Ucraina 299
FI - Finlandia 270
FR - Francia 219
IN - India 163
GB - Regno Unito 137
CH - Svizzera 106
JO - Giordania 94
AU - Australia 91
TR - Turchia 58
JP - Giappone 52
CA - Canada 45
CI - Costa d'Avorio 44
NL - Olanda 40
BD - Bangladesh 39
ID - Indonesia 39
IQ - Iraq 38
AR - Argentina 36
ES - Italia 32
MX - Messico 27
ZA - Sudafrica 22
PK - Pakistan 21
EC - Ecuador 20
AT - Austria 17
SA - Arabia Saudita 16
UZ - Uzbekistan 16
BE - Belgio 14
VE - Venezuela 14
MA - Marocco 12
SC - Seychelles 12
AZ - Azerbaigian 11
DZ - Algeria 9
PH - Filippine 9
KE - Kenya 8
NG - Nigeria 8
BG - Bulgaria 7
CO - Colombia 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
MY - Malesia 6
PA - Panama 6
PE - Perù 6
TN - Tunisia 6
EG - Egitto 5
OM - Oman 5
RO - Romania 5
UY - Uruguay 5
EU - Europa 4
IL - Israele 4
KG - Kirghizistan 4
NI - Nicaragua 4
NP - Nepal 4
AL - Albania 3
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LT - Lituania 3
PS - Palestinian Territory 3
SN - Senegal 3
BJ - Benin 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GD - Grenada 2
HN - Honduras 2
IR - Iran 2
KH - Cambogia 2
LV - Lettonia 2
MM - Myanmar 2
MU - Mauritius 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
NE - Niger 1
Totale 26.032
Città #
Warsaw 2.411
Santa Clara 2.029
Fairfield 1.330
Ashburn 1.280
Singapore 903
Chandler 655
Hong Kong 646
Woodbridge 643
Dublin 580
Seattle 579
Cambridge 523
Houston 469
Wilmington 464
Jacksonville 459
Seoul 388
San Jose 370
Beijing 225
Ann Arbor 216
Altamura 204
Dallas 196
Lawrence 196
Florence 193
Princeton 184
Buffalo 179
The Dalles 170
Los Angeles 147
Lauterbourg 145
Ho Chi Minh City 137
Boardman 128
Boston 122
Hefei 100
Bern 98
Hanoi 97
Melbourne 91
New York 86
San Diego 85
Munich 83
Helsinki 81
Mumbai 81
Medford 74
Council Bluffs 71
Moscow 66
Shanghai 63
Falls Church 57
Tokyo 49
Abidjan 44
Kent 42
Dong Ket 40
Norwalk 40
Milan 39
Izmir 38
Turku 34
Jakarta 29
Paris 29
São Paulo 29
Bremen 28
Clifton 28
Pune 26
Haiphong 24
Andover 23
Orem 23
Phoenix 23
Auburn Hills 22
Redondo Beach 21
Chicago 20
Yubileyny 19
Guangzhou 18
Hillsboro 18
Chennai 17
Frankfurt am Main 17
Toronto 17
Vienna 16
Da Nang 15
London 15
Johannesburg 14
Rio de Janeiro 14
Tashkent 14
Brooklyn 13
Brussels 13
Rome 13
Stockholm 13
Biên Hòa 12
Denver 12
Frankfurt Am Main 12
Shenzhen 12
Verona 12
West Jordan 12
Atlanta 11
Baghdad 11
Baku 11
Redwood City 11
Barcelona 10
Amsterdam 9
Brescia 9
Guayaquil 9
Abuja 8
Belo Horizonte 8
Lahore 8
Manchester 8
Mexico City 8
Totale 18.394
Nome #
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 437
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions 377
A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules. 370
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 368
Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. 357
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 327
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 321
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 315
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 308
Multiparametric analysis of cell-free DNA in melanoma patients. 303
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 302
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 298
Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics 297
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing 288
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 287
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 286
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 277
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 265
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 242
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 240
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 212
A real-time quantitative PCR assay for the detection of Sphaeropsis sapinea from inoculated Pinus nigra shoots 210
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 208
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 206
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 205
Glycated hemoglobin (HbA1c) measurement in frozen whole blood depends on baseline values of fresh samples. 203
The pre-analytical phase of the liquid biopsy 203
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 200
The genes that codify angiotensin converting enzyme and type 1 receptor for angiotensin II have a different effect on longevity 199
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 198
null 196
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 193
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. 191
Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. 187
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 186
Centenarians in Tuscany: The role of the environmental factors. 186
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 185
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 185
Red or white wine assumption and serum antioxidant capacity. 185
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 185
Age-related changes in serum total antioxidant capacity (TAC), dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1): evidence in healthy centenarian subjects. 183
Age-related secretion of androstenedione, testosterone and dihydrotestosterone by the human testis. 180
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 180
Circulating tumour cells in colorectal cancer 179
Real-time PCR detection of Biscogniauxia mediterranea in symptomless oak tissue 177
Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 176
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. 175
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 174
Circulating cell-free DNA in cancer 173
Combining qualitative and quantitative imaging evaluation for the assessment of genomic DNA integrity: The SPIDIA experience 172
luciferase gene as reporter: comparison with CAT gene and use in transfection and microinjection of mammalian cells 171
Measurement of steroids in human plasma and tissues by isotope dilution mass spectrometry. 170
A solid phase chemiluminescent immunoassay (LIA) for testosterone glicuronide in diluted urines. 169
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. 168
Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. 167
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 167
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer 166
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. 166
Laser microdissection on Norway spruce bark tissue: A suitable protocol for subsequent real-time reverse transcription–polymerase chain reaction (RT-PCR) analysis 165
Longevity index (LI%) and centenarity index (CI%): New indicators to evaluate the characteristics of aging process in the Italian population. 165
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 164
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 164
NUCLEOSIDE ANALOGUES AS RADIOSENSITIZERS IN THE TREATMENT OF LUNG CANCER 163
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. 163
Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. 162
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. 162
Analysis of 12q13-15 genes in parosteal osteosarcoma 161
Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique 160
Biological parameters for the choice of antiangiogenic therapy and efficacy monitoring 160
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma 159
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 157
Detection of Diplodia pinea in asymptomatic pine shoots and its relation to the Normalized Insolation index 157
Healthy centenarian subjects as living model of "successful aging": A study on fasting glycemia, C-peptide, dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor (IGF-1). 155
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors 154
Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training. 152
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. 152
Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. 150
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients 150
Telomerase in urological malignancy 149
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 149
An immunoassay for plasma cortisol based on chemiluminescence. 148
Healthy centenarian subjects: the effect of red wine consumption on liver function tests. 148
Evaluation of the liquid biopsy for the detection of brafv600e mutation in metastatic melanoma patients 148
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer. 147
Effects of gemcitabine in normal and transformed human lung cell cultures: citotoxicity and increase of radiation sensitivity 146
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. 145
Melting temperature analysis as quantitative method for detection of point mutations. 144
Tyrosinase mRNA levels in the blood ofuveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. 144
An assay procedure for plasma progesterone based on antibody-enhanced chemiluminescence. 142
Evaluation of different progesterone-isoluminol conjugates for chemiluminescence immunoassay. 140
Studio prospettico sul carcinoma del colon e angiogenesi: risultati preliminari 140
Effect of diet and red wine consumption on serum total antioxidant capacity (TAC), dehydroepiandrosterone-sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1) in Italian centenarians. 139
Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. 138
Spermatic and peripheral oestradiol levels in patients affected by azoospermia due to seminiferous tubular damage. 135
Circulating nucleic acids in cancer and pregnancy 135
Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experience 135
The meat in the diet of aged subjects and the antioxidant effects of carnosine. 134
Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience 134
ATP chemosensitivity testing: methodology and comparison with other methods 133
QUANTITATIVE POLYMERASE CHAIN REACTION-BASED HOMOGENEOUS ASSAY WITH FLUOROGENIC PROBES TO MEASURE C-ERBb-2 ONCOGENE AMPLIFICATION. 132
Totale 19.581
Categoria #
all - tutte 69.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 0 121 155
2021/20221.160 30 80 79 40 77 81 50 60 76 62 198 327
2022/20232.943 295 557 87 253 243 501 349 155 280 18 73 132
2023/2024967 50 119 168 50 61 140 43 196 15 28 66 31
2024/20256.154 199 660 376 1.013 1.868 666 99 424 302 160 214 173
2025/20266.177 759 928 518 503 815 265 950 366 481 429 163 0
Totale 26.193